TH13346A - อนุพันธ์ควินูคลิดีน - Google Patents
อนุพันธ์ควินูคลิดีนInfo
- Publication number
- TH13346A TH13346A TH9201000691A TH9201000691A TH13346A TH 13346 A TH13346 A TH 13346A TH 9201000691 A TH9201000691 A TH 9201000691A TH 9201000691 A TH9201000691 A TH 9201000691A TH 13346 A TH13346 A TH 13346A
- Authority
- TH
- Thailand
- Prior art keywords
- compound
- formula
- methyl
- amine
- octan
- Prior art date
Links
- 150000008584 quinuclidines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 46
- -1 ter-butyl Chemical group 0.000 claims abstract 21
- 239000000126 substance Substances 0.000 claims abstract 16
- 150000003839 salts Chemical class 0.000 claims abstract 9
- 238000011282 treatment Methods 0.000 claims abstract 5
- 208000002193 Pain Diseases 0.000 claims abstract 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims abstract 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims abstract 3
- 230000036407 pain Effects 0.000 claims abstract 3
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 claims abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 claims abstract 2
- 102100024304 Protachykinin-1 Human genes 0.000 claims abstract 2
- 101800003906 Substance P Proteins 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 9
- JASMWYNKLTULAN-UHFFFAOYSA-N octan-3-amine Chemical compound CCCCCC(N)CC JASMWYNKLTULAN-UHFFFAOYSA-N 0.000 claims 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 238000004519 manufacturing process Methods 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 5
- 208000035475 disorder Diseases 0.000 claims 5
- 230000003301 hydrolyzing effect Effects 0.000 claims 5
- 230000002265 prevention Effects 0.000 claims 5
- 208000033808 peripheral neuropathy Diseases 0.000 claims 3
- 208000019901 Anxiety disease Diseases 0.000 claims 2
- 208000027932 Collagen disease Diseases 0.000 claims 2
- 206010012335 Dependence Diseases 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 201000002481 Myositis Diseases 0.000 claims 2
- 208000028017 Psychotic disease Diseases 0.000 claims 2
- 208000025747 Rheumatic disease Diseases 0.000 claims 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims 2
- 230000007815 allergy Effects 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- 210000004556 brain Anatomy 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 239000003638 chemical reducing agent Substances 0.000 claims 2
- 238000013329 compounding Methods 0.000 claims 2
- 230000006835 compression Effects 0.000 claims 2
- 238000007906 compression Methods 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 150000002466 imines Chemical class 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 206010022437 insomnia Diseases 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000002858 neurotransmitter agent Substances 0.000 claims 2
- 208000024335 physical disease Diseases 0.000 claims 2
- 238000011321 prophylaxis Methods 0.000 claims 2
- 230000011514 reflex Effects 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 claims 2
- 210000000278 spinal cord Anatomy 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- GDSLUYKCPYECNN-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[(4-fluorophenyl)methyl]benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCC2=CC=C(C=C2)F)C=CC=1 GDSLUYKCPYECNN-UHFFFAOYSA-N 0.000 claims 1
- 206010009126 Chronic respiratory failure Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 101150084935 PTER gene Proteins 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 230000005856 abnormality Effects 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- SJSWRKNSCWKNIR-UHFFFAOYSA-N azane;dihydrochloride Chemical compound N.Cl.Cl SJSWRKNSCWKNIR-UHFFFAOYSA-N 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 229940126214 compound 3 Drugs 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 239000002274 desiccant Substances 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- HQPBPHWHPVDJQU-UHFFFAOYSA-N methanesulfonic acid;octan-3-amine Chemical compound CS(O)(=O)=O.CCCCCC(N)CC HQPBPHWHPVDJQU-UHFFFAOYSA-N 0.000 claims 1
- KXMTXZACPVCDMH-UHFFFAOYSA-N methyl 4-[5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl]-7-methoxy-1,3-benzodioxole-5-carboxylate Chemical compound COC(=O)C1=CC(OC)=C2OCOC2=C1C1=C2OCOC2=C(OC)C=C1CO KXMTXZACPVCDMH-UHFFFAOYSA-N 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 230000000926 neurological effect Effects 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 230000037311 normal skin Effects 0.000 claims 1
- OUSJHHILXRLTDF-UHFFFAOYSA-N octan-3-amine;dihydrochloride Chemical compound Cl.Cl.CCCCCC(N)CC OUSJHHILXRLTDF-UHFFFAOYSA-N 0.000 claims 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 239000005426 pharmaceutical component Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 201000004193 respiratory failure Diseases 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 208000010643 digestive system disease Diseases 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 208000018685 gastrointestinal system disease Diseases 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
Abstract
สารประกอบของสูตร (สูตรเคมี) โดยที่ R1 คือเมทธอกซี และ R2 เลือกได้โดยอิสระจากหมู่ที่ประกอบด้วยไอโซโพรพิล, เทอร์-บิวทิล, เมทธิล, เอทธิล และเช็คบิวทิล และเกลือทียอมรับได้ในทางเภสัชกรรมของสารประกอบนี้ สารประกอบเหล่านี้ คือสารแอนทาโกนิสของสาร P และใช้ประโยชน์ได้ในการบำบัดรักษา โรคในกระเพาะลำไส้, อาการอักเสบโรคภัยในระบบประสาทส่วนกลางและอาการปวด สิทธิบัตรยา
Claims (1)
1. (2S, 3S)-N-(5-ไอโซโพรพิล-2-เมทธอกซีเฟนนิล)เมทธิล-2-ไดเฟนนิลเมธิล-1-อะซาไบไซโคล[2.2.2]ออคแทน-3-เอมีนไดไฮโดรคลอไรด์
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH13346A true TH13346A (th) | 1993-11-15 |
| TH11522B TH11522B (th) | 2001-12-21 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2232008C (en) | Use of epinastine for the treatment of pain | |
| US11738023B2 (en) | Treatment and prevention of sleep disorders | |
| DE69424853T2 (de) | Morphinan-derivate und ihre medizinische verwendung | |
| TW533211B (en) | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 | |
| US4544669A (en) | Compounds and compositions useful for producing analgesia | |
| BRPI0908421B1 (pt) | Solução estável de um composto farmacêutico | |
| ATE322283T1 (de) | Transdermale verwendung von sekretin zur behandlung von autismus | |
| JPS6084251A (ja) | 鎮痛用新規化合物および組成物 | |
| GB2144416A (en) | Novel compounds and compositions useful for producing analgesia | |
| BRPI0912604A2 (pt) | quinolinilmetilimidazóis como agentes terapêuticos | |
| ID29025A (id) | Fenilalkenoilguanidina-fenilalkenoilguanidina yang disubstitusi asam empedu, proses pembuatannya, penggunaannya sebagai obat atau diaknostik dan obat-obat yang mengandungnya | |
| JP2023510865A (ja) | 血管脂肪腫の処置のための組成物 | |
| TH13346A (th) | อนุพันธ์ควินูคลิดีน | |
| TH11522B (th) | อนุพันธ์ควินูคลิดีน | |
| EP1059090A1 (en) | Remedies for brain infarction | |
| DE60215195T2 (de) | Derivate morphinähnlicher opioidverbindungen | |
| EP0528749B1 (en) | Indole derivatives and their use | |
| CH637370A5 (en) | Racemic forms and optically active forms of 2-(4-biphenylyl)-N-(diethylaminoalkyl)-propionamide, salts thereof and relative preparation processes | |
| EP0187009B1 (en) | Compounds and compositions having anti-inflammatory and analgesic activity | |
| JPH02502920A (ja) | てんかんの発作の治療用製薬組成物 | |
| EA000951B1 (ru) | Способ лечения боли висцерального происхождения | |
| JP2024506228A (ja) | 脂質関連障害の処置のための組成物および方法 | |
| WO2019197015A1 (en) | Composition comprising 4-phenylbutyric acid derivatives & opioids | |
| Shannon et al. | Xanomeline: An Efficacious and Specific M1 Receptor Agonist—Preclinical Update | |
| US10646457B2 (en) | Emesis treatment |